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ABSTRACT KEY WORDS
Transgenic mice of line M[P3 express
bacterial [$.galactosidase in oligodendrocytes but
not other cells of the CNS. The marker enzyme,
demonstrated histochemically or by immuno-
staining in oligodendrocyte cell bodies and along
myelin internodes, appears at the time of
myelination and persists thereafter; in
transplantation experiments, the marker may
serve to indicate both the source of particular
cells and their state of differentiation. The
subventricular zone of the lateral ventricle,
grafted from transgenic to wild-type perinatal
recipient mice, yielder histochemically labeled
oligodendrocytes in surrounding host tissue.
When grafts ar.e placed in cerebral cortex near
callosal radiations, graft-derived oligodendro.
cytes are found in cerebral cortex and
subcortical white matter as far as 1.5 mm from
the site of implant but not in nearby
caudoputamen. This study is the first to
document differentiation of transplant-derived
oligodendrocytes in normal developing CNS.
Our results are consistent with the well-
established notion that oligodendrocyte
progenitors migrate during normal development
and suggest that such migration might be guided
or restricted by mechanisms yet to be identified.
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INTRODUCTION
The behavior of transplanted oligodendrocytes
and oligodendrocyte progenitors in normal host
tissue has largely been obscured by a lack of
effective markers. Previous studies have
demonstrated migration of transplanted
oligodendrocytes or their progenitors into host
CNS experimentally depleted of oligodendrocytes
or genetically dysmyelinated /5/; however, the
behavior of oligodendrocytes and their progenitors
transplanted into normal developing CNS remains
largely unexplored.
MIP, recently constructed in our laboratory, is a
chimeric gene containing the E.coli lacZ (-
galactosidase) coding sequence flanked by
segments of the murine myelin basic protein
(MBP) and myelin proteolipid protein genes. This
construct is expressed strongly and specifically in
oligodendrocytes, whose cell bodies and processes
are readily visualized in transgenic mice by X-gal
histochemical staining and by immunofluorescence
for the transgene protein/2/. Transgene expression
is negligible at birth and increases dramatically as
myelination progresses; it parallels that of the
endogenous MBP gene, both in vivo and in
dispersed cell culture.
The transgenic mice show normal CNS
architecture and are well myelinated. Since the
transgene has no evident effect on development or
function of the CNS, it is a suitable marker for
transplantation studies. In the studies described
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here, we transplanted tissue pieces from brains of
M3P transgenic mice into those of perinatal wild
type hosts and obtained labeled, differentiated
oligodendrocytes in host structures. In this first
view of the behavior of oligodendrocyte/progenitor
cells transplanted into normal CNS, we find clear
evidence that cells of this lineage migrate out of
transplants, and that such migration is guided or
restricted by host structures.
MATERIALSAND METHODS
The MIP transgene and lineMP3
The M3P transgene, described in detail
elsewhere/2/, consists of the lacZ gene of E.coli
flanked upstream t-_ a 1.9 kb fragment of the
promoter-enhancer region of the murine MBP gene
and downstream by a fragment of the human
myelin proteolipid (PLP) gene. Line MP3 is one
of several generated with this construct; it was
chosen for the present study because the line shows
strong expression of the transgene, limited to
oligodendrocytes /2/. Donor mice were obtained
from matings of heterozygous transgenics (Tg/-) of
a mixed C57Bl/6J x DBA/2J background with wild
type (-/-) mice which were the F1 progeny of those
two inbred strains. The donor litters were mixed
Tg/- and wild type; the genotype of each donor was
determined by X-gal staining of spinal cord pieces,
as described below.
Transplantation
Donor mouse pups, from 1 to 3 days after birth,
were sacrificed by decapitation. Brains were
removed and slices of brain were laid flat in sterile
Petri dishes. Each slice was penetrated at the
dorsolateral margin of the lateral ventricle by a 5
Hamilton syringe equipped with a blunt-ended 25
ga needle mounted on a stereotaxic device, and a
volume of 0.1-0.2 tl of tissue was drawn into the
needle. Recipient mice of similar age were
anesthetized by hypothermia and placed in the
stereotaxi device. Following craniotomy, the
loaded syringe needle was lowered into the cerebral
cortex, and the plug of tissue it contained was
ejected approximately 0.5-1 mm caudal to bregma,
I mm from the midline, and I mm from the cortical
surface. Following withdrawal of the needle, the
wound was closed and the pups were returned to
their mothers.
Histochemistry
At least 30 days post-transplantation, recipients
were anesthetized and fixed by vascular perfusion
with buffered formaldehyde. Brains were removed
and coronal sections were cut serially at 50 Ixm
thickness on a Vibratome. Sections were stained
for bacterial 13-galactosidase by incubation in a
solution containing 0.15 M NaCI, 10 mM
Na2HPO4, 35 mM K3Fe(CN)6, 35 mM K4Fe(CN)6,
2 mM MgC12, 0.01% sodium deoxycholate, 0.02%
Nonidet NP-40 (Sigma) and 0.05% X-gal (5-
bromo-4-chloro-3-indolyl-[5-galactoside; GIBCO-
BRL), final pH 7.0. Sections were examined
without counterstaining using brightfield, phase
and Nomarski optics; illustrations for this paper
were obtained with brightfield optics.
RESULTS
Histochemicai characterization of transgenically
labeled oligodendrocytes
The MI3P3 transgene drives expression of a
bacterial [3-galactosidase coding sequence in
oligodendrocytes but not in other cells of the CNS
/2/. Reaction conditions specific for the bacterial
enzyme yielded strong histochemical staining of
white matter in transgenic mice (Fig. 1A), with no
staining of wild type (nontransgenic) controls (Fig.
1B). Stained cell bodies were clearly visible in the
transgenic white matter, surrounded by diffusely
distributed reaction product, and also occurred in
those gray matter regions containing myelinated
axons (Fig. 2).
Oligodendrocytes emit numerous processes
joining cell bodies with their myelin sheaths, and
Golgi-impregnated oligodendrocytes were readily
identified by their characteristic shapes/6/. These
processes were also visible in X-gal stained
sections from the transgenic mice (Fig. 3),
indicating that the marker enzyme was present,
within processes, at a distance from the cell body.
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Fig. 1: Sagittal sections from the brains of an MIBP3 transgenic mouse (A) and a control (wild type) mouse (B), stained with X-
gal for bacterial I3-galactosidase. The transgenic mouse shows strong staining of white matter throughout the brain, while
the control mouse shows no staining. Scale bar, 1 mm.
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Fig. 2:
ML
Cerebellum of MI3P mouse, stained with X-gal. Oligodendrocyte cell bodies are stained darkly in the subcortical white
matter (WM) and in the granular layer (GL), which contains dispersed myelinated axons. Staining is absent from the
molecular layer, which contains no myelin. Diffuse staining of the subcortical white matter represents enzyme in the
cytoplasmic loops of myelin sheaths. Scale bar, 100 Ftm.
Fig. 3: Caudoputamen of an M[SP transgenic mouse, stained with X-gal. Oligodendrocyte cell bodies are clearly visualized.
Characteristic stained processes (arrowheads) join the cell bodies with nearby stained myelinated bundles(M). Scale bar,
20 lam.
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Individual X-gal stained myelinated axons could
often be followed in gray matter, indicating that the
enzyme was also present in the cytoplasmic loops
of myelin sheaths.
CNS transplants yield transgenically labeled
oligodendrocytes
Tissue plugs from perinatal M[BP3 transgenic
mouse brain were placed into the cerebra of
perinatal wild type hosts. At the time of
transplantation, few oligodendrocytes were present
in either donor or host brains. Recipients were
sacrificed at age four weeks or beyond, a survival
interval sufficient to allow substantial myelination
of host mouse brain (e.g. /4,7/) and robust
expression of the transgene /2/. X-gal stained
sections contained labeled cells, isolated or in
groups, with morphology identical to that of
oligodendrocytes in the native transgenic mice
(Fig. 4).
Distribution of labeled oligodendrocytes
Tissue plugs 0.1-0.2 tl in volume were
extracted from the subventricular zone of perinatal
transgenic donor mice and implanted into perinatal
recipients. The site of extraction was the
dorsolateral edge of the lateral ventricle; the site of
implant was in the nearby cerebral cortex (Fig. 5).
After 30 days or more survival, we found graft-
derived oligodendrocytes mainly in subcortical
white matter and callosal radiations, with a smaller
number of cells in overlying cerebral cortex. A few
cells were located in the fornix and ventral
hippocampal commissure, near their contact with
the corpus callosum. We found no evidence of long
distance migrations like those obtained when host
mice are dysmyelinated/5/, but the design of our
experiments may not have favored such migrations.
We did not see labeled cells in the
caudoputamen, even that immediately subjacent to
labeled subcortical white matter. Since geometry
appears to favor passage of cells into the
caudoputamen, we wondered if the caudoputamen
might present an environment hostile to the
differentiation of the engrafted cells. Deeper
implants excluded that possibility: numerous [5-
galactosidase-positive, myelin-forming cells were
found within the caudoputamen when transgenic
preparations were inserted directly into that region
(Fig. 6).
DISCUSSION
The subventricular zone of the lateral ventricle
is thickened at the ventricle’s dorsolateral margin.
This region is the site of intense mitosis during
postnatal development, giving rise to oligodendro-
cyte precursors which, dividing further, populate
the cerebral cortex and subcortical white matter and
finally differentiate (e.g. /1,3/). In the present
study, we removed small pieces from this area of
the subventricular zone of transgenic mice and
placed them in nearby cerebral cortex of wild type
hosts. The tissue pieces contained no
galactosidase-positive cells at the time of
transplantation but did give rise to [B-galactosidase-
positive oligodendrocytes during subsequent
development, indicating that the subventricular
zone is an effective source of oligodendrocyte
progenitors. The transplant-derived oligodendro-
cytes were dispersed in subcortical white matter
and cerebral cortex near the grafts, indicating that
oligodendrocytes or, more likely, their progenitors
migrated from the grafted tissue plugs into
surrounding host tissue.
In the developing oligodendrocytes of immature
M[P3 transgenic mice, double immunofluor-
escence shows that transgene expression initiates
after the expression of cyclic nucleotide
phosphohydrolase and concomitant with the
expression of the native MBP gene /2/. The
presence of the transgenic [B-galactosidase in the
transplant recipients thus indicates that the graft-
derived oligodendrocytes are differentiated to the
point of expressing MBP. That many of these
engrafted cells make myelin sheaths is strongly
suggested by the characteristic histochemical
staining pattern found around labeled somas,
attributed to transplant-derived oligodendrocyte
processes and myelin sheaths (Fig. 4B).
Transgenic oligodendrocytes were common in
dorsal subcortical white matter but they did not
appear in myelinated bundles of the caudoputamen.
These bundles are in direct continuity with the
subcortical white matter (Fig. 5) and, in fact,
VOLUME 4, NO. 2, 1993144 V.L. FRIEDRICH AND R. A. LAZZARINI
Fig. 4: Transplant-derived oligodendrocytes and myelin,
visualized by X-gal staining. A: distribution of X-
gal stain following engraftment into cerebral cortex
is limited to cerebral cortex and subjacent white
matter. B: Cell bodies are labeled, as are myelin
sheaths derived from the labeled cells. Scale bars: 1
mm (A); 100 lxm (B).
Fig. 5: Distribution of labeled oligodendrocytes after implantation in cerebral cortex near subcortical white matter; mouse brain
viewed in coronal section. Labeled oligodendrocytes (boxes) are distributed in callosal radiations, subcortical white
matter and cerebral cortex but not in nearby caudoputamen. The approximate site of implants is indicated by the large
arrow. The small arrow indicates one of many points of continuity between subcortical white matter and myelinated axon
bundles of the caudoputamen. The diagram is a schematic summarizing the results from eight animals. Scale bar, 1 mm.
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Fig. 6: Labeled oligodendrocytes are dispersed in the caudoputamen after deeper implant of transgenic cells, indicating that the
caudoputamen is capable of supporting the differentiation of transplanted, transgenic oligodendrocytes when implanted in
that structure.
contain axons which run to and from the
subcortical white matter. Although no barrier to
migration between the two regions is apparent, it
appears that oligodendrocyte progenitors migrated
along the subcortical white matter without entering
the contiguous caudoputamen. This single example
suggests that migration of transplanted oligo-
dendrocyte progenitors, and quite possibly that of
endogenous oligodendrocyte progenitors as well, is
directed or restricted by mechanisms yet to be
identified.
The strategy employed here uses a transgene so
structured that its marker enzyme is expressed only
in differentiated cells of a particular phenotype.
This approach does not mark undifferentiated cells
nor ceils of other types; in transplantation
experiments, the presence of the marker documents
simultaneously the source and the state of
differentiation of the marked cells. In this study, we
found that the transplanted subventricular zone
gives rise to differentiated oligodendrocytes which
populate the host tissue surrounding the grafts. This
approach may prove fruitful in further analysis of
oligodendroglial migration and differentiation
during development and of transplant contribution
to repair from demyelination.
ACKNOWLEDGEMENTS
This is publication #124 from the Brookdale
Center for Molecular Biology of the Mount Sinai
School of Medicine. These studies were supported
by NIH grant NS29056 (R.L.) and grants RG-2238-
A-1 (R.L.) and PP0220 (V.F.) from the National
Multiple Sclerosis Society. We thank Xue Li for
his excellent technical contributions.
REFERENCES
1. Goldman JE, Vaysse PJ-J. Tracing glial cell lineages in
the mammalian forebrain. Glia 1991; 4: 149-156.
2. Gow A, Friedrich VL Jr, Lazzarini RA. Myelin basic
protein gene contains separate enhancers for
VOLUME 4, NO. 2, 1993146 MIGRATION OF TRANSPLANTED OLIGODENDROCYTE LINEAGE
oligodendrocyte and Schwann cell expression. J Cell
Biol 1992; 119: 605-616.
3. Hardy R, Reynolds R. Proliferation and differentiation
potential of rat forebrain oligodendroglial progenitors
both in vitro and in vivo. Development 1991; 111:
1061-1080.
4. Horrocks LA. Composition of mouse brain myelin
during development. J Neurochem 1968; 15: 483-488.
5. Lachapelle F, Lapie P, Gansmuller A, Villarroya H,
Baumann N, Guinpel M. What have we learned about
the jimpy phenotype expression by intraeerebral
transplantations? In: Duncan ID, Skoff RP, Colman D,
eds, Myelination and Dysmyelination. New York: New
York Academy of Sciences, 1990; 332-345.
6. Rio-Hortega P del. Tercera aportaci6n al conoeimiento
morfol6gico e interpretaei6n functional de la
oligodendroglia. Mere R See Exp Hist Nat 1928; 14: 5-
122.
7. Sturrock RR. Myelination of the mouse corpus
callosum. Neuropathol Appl Neurobiol 1980; 6: 415-
420.
JOURNAL OF NEURAL TRANSPLANTATION & PLASTICITY